La Crosse Virus Nucleocapsid (LACV N) (AA 90-140) anticorps

N° du produit ABIN5690036

Cet anticorps anti-La Crosse Virus Nucleocapsid Polyclonal Lapin (ABIN5690036) détecte spécifiquement La Crosse Virus Nucleocapsid dans ELISA. L’anticorps est réactif avec des échantillons de Virus.

Aperçu rapide pour La Crosse Virus Nucleocapsid (LACV N) (AA 90-140) anticorps (ABIN5690036)

Antigène: La Crosse Virus Nucleocapsid (LACV N)

Reactivité: Virus

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Inconjugué

Application: ELISA

Détail du produit

Épitope: AA 90-140

Purification: La Crosse Virus Nucleocapsid Antibody is affinity chromatography purified via peptide column.

Immunogène: La Crosse virus nucleocapsid antibody was raised against an 18 amino acid peptide near the center of the La Crosse virus nucleocapsid.

The immunogen is located within amino acids 90 - 140 of La Crosse Virus Nucleocapsid.

Isotype: IgG

Information d'application

Indications d'application: La Crosse virus nucleocapsid antibody can detect 10 ng La Crosse virus nucleocapsid peptide in ELISA at 1 μ,g/mL.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: La Crosse virus nucleocapsid Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Rift Valley Fever Virus Nucleocapsid antibody can be stored at 4°C for three months and -20°C, stable for up to one year.

Détail du antigène

Antigène: La Crosse Virus Nucleocapsid (LACV N)

Autre désignation: La Crosse Virus Nucleocapsid

Classe de substances: Viral Protein

Sujet: La Crosse Virus Nucleocapsid Antibody: La Crosse virus (LCV) is a single-stranded RNA virus that can cause encephalitis in humans and is transmitted predominantly by mosquitoes. It is often mistaken for herpes simplex encephalitis (1). During human infections, LCV initially presents as a nonspecific summertime illness with fever, headache, nausea, vomiting and lethargy. Death occurs in less than 1 % of clinical cases.

Poids moléculaire: Predicted: 26 kDa

ID gène: 956556

UniProt: Q8JPR0